PharMerica FCA Decision Is A Win For Statutory Interpretation

By David Lieberman and Erica Hitchings (March 2, 2020, 4:14 PM EST) -- On Feb. 19, the U.S. Court of Appeals for the First Circuit issued a decision in U.S. ex rel. Banigan & Templin v. PharMerica Inc., a long-running False Claims Act suit.[1] The plaintiffs allege that PharMerica, one of the largest long-term care pharmacy companies in the U.S., illegally used kickbacks to induce nursing homes to purchase its drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as